H1B Atlas
AP
PERM FY2024-FY2025NAICS 32541

Agios Pharmaceuticals, Inc. PERM Filings

Public PERM filing activity, approval signal, filed wage evidence, beneficiary countries, law firms, and role mix for Agios Pharmaceuticals, Inc..

Updated 2026-05-23
View H-1B profile

PERM filings

4records

Approval rate

25%FY2024-FY2025

Median filed wage

$131,425base wage

Denied filings

0PERM records

Top country

N/A
LCA filings are not visa approvals or open roles — see why this matters
Public filing data is normalized for browsing. LCA filings are not visa approvals or job openings, PERM filings are not individual green-card success rates, and salary figures generally use the lower bound of filed wage ranges and exclude equity, bonus, and benefits. PERM pages describe employer filing activity and should not be read as legal advice or a prediction of an individual case outcome.

Top PERM roles

  • Pharmacometrics Data Scientist1
    $77,210
  • Principal Statistical Programmer1
    $82,555
  • Associate Director, Statistical Programming1
    $208,000
  • Associate Manager, Regulatory Operations1
    $180,294

Top law firms

  • Webber Law Firm 2.0, LLC2
  • Webber Arredondo Oja, LLC.1
  • Dorsey & Whitney LLP1

Frequently Asked Questions

How many PERM filings does Agios Pharmaceuticals, Inc. have?
Agios Pharmaceuticals, Inc. has 4 PERM filings in the available FY2024-FY2025 dataset.
What is the PERM approval rate for Agios Pharmaceuticals, Inc.?
The observed PERM approval rate for Agios Pharmaceuticals, Inc. is 25% based on certified and denied filings in the available dataset.
Which PERM roles appear most often for Agios Pharmaceuticals, Inc.?
Common PERM roles for Agios Pharmaceuticals, Inc. include Pharmacometrics Data Scientist, Principal Statistical Programmer, Associate Director, Statistical Programming.
Which beneficiary countries appear most often in Agios Pharmaceuticals, Inc. PERM filings?
The available PERM profile for Agios Pharmaceuticals, Inc. does not expose enough country concentration for a top-country summary.